Skip to main content
. 2016 Oct 22;31(6):749–759. doi: 10.1093/her/cyw046

Table II.

Primary hypotheses: effects of treatment condition (versus IT) on maintenance of tobacco abstinence and medication use

Intervention versus IT Treated-as-intended
Intention-to-treat
12mPA from tobacco
Attain (%) χ 2(1) NNT OR 95% CI Attain (%) χ 2(1) NNT OR 95% CI
ENS 15.7 versus 3.8 6.92** 8.4 4.72 1.35, 16.53 8.4 versus 7.1 0.26 1.20 0.59, 2.44
Harm reduction 13.6 versus 3.8 5.26* 10.2 3.99 1.13, 14.09 7.9 versus 7.1 0.09 1.12 0.55, 2.28
Intervention versus IT Days since last cigarette
Mean (SD) t(322) Mean (SD) t(805)
ENS 115.42 (248.07) versus 22.48 (90.46) 3.00** 61.67 (186.04) versus 39.38 (126.82) 1.37
Harm reduction 100.33 (233.83) versus 22.48 (90.46) 2.53* 55.99 (177.60) versus 39.38 (126.82) 1.02
Intervention versus IT 7dPP tobacco abstinence
Attain (%) χ2(1) NNT OR 95% CI Attain (%) χ2(1) NNT OR 95% CI
ENS 22.3 versus 12.7 2.96 + 10.4 1.98 0.90, 4.36 13.1 versus 14.8 0.27 0.87 0.51, 1.48
Harm reduction 20.8 versus 12.7 2.21 1.81 0.82, 4.00 12.3 versus 14.8 0.62 0.81 0.47, 1.38
Intervention versus IT Medication use
Attain (%) χ2(1) NNT OR 95% CI Attain (%) χ2(1) NNT OR 95% CI
ENS 77.7 versus 43.0 24.90*** 2.9 4.61 2.49, 8.55 44.5 versus 36.1 3.26 + 11.9 1.42 0.97, 2.09
Harm reduction 84.0 versus 43.0 37.41*** 2.4 6.95 3.62, 13.36 52.2 versus 36.1 11.50*** 6.2 1.93 1.32, 2.84
Intervention versus IT Days using medication
Mean (SD) t(322) Mean (SD) t(805)
ENS 86.50 (140.85) versus 21.33 (51.04) 3.90*** 37.38 (97.97) versus 21.41 (58.13) 1.94 +
Harm reduction 75.67 (117.60) versus 21.33 (51.04) 3.27*** 36.17 (86.75) versus 21.41 (58.13) 1.79 +

Note. 12mPA from tobacco = 12-month prolonged abstinence from tobacco; 7dPP tobacco abstinence = 7-day point prevalence tobacco abstinence; Attain (%) = percentage who attained outcome; NNT = number needed to treat; OR = odds ratio; 95% CI = 95% confidence interval

+

P   < 0.10,

*P  < 0.05,

** P < 0.01,

*** P < 0.001